Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia

•NO pathway seems to play a central role in uteroplacental changes during pregnancy.•Preeclampsia (PE) is associated with endothelial dysfunction.•Polymorphism in eNOS gene compromises NO bioavailability.•It has been admitted that early PE and late PE are different diseases.•Contradictory conclusion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nitric oxide 2014-11, Vol.42, p.19-23
Hauptverfasser: Alpoim, Patrícia Nessralla, Gomes, Karina Braga, Pinheiro, Melina de Barros, Godoi, Lara Carvalho, Jardim, Letícia Lemos, Muniz, Ludmila Gomes, Sandrim, Valéria C., Fernandes, Ana Paula, Dusse, Luci Maria S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•NO pathway seems to play a central role in uteroplacental changes during pregnancy.•Preeclampsia (PE) is associated with endothelial dysfunction.•Polymorphism in eNOS gene compromises NO bioavailability.•It has been admitted that early PE and late PE are different diseases.•Contradictory conclusions have been reported regarding eNOS gene polymorphisms and PE. Preeclampsia (PE) is characterized by hypertension and proteinuria, occurring after the 20th week of pregnancy in women who have had no previous symptoms. The disease progresses with generalized vasoconstriction and endothelial dysfunction. Clinically, it is important to diagnose the severe form of the disease (sPE), in which blood pressure and proteinuria are much higher. Recently, the gestational age (GA) of the onset of PE has led to the classification of this disease as early (GA
ISSN:1089-8603
1089-8611
DOI:10.1016/j.niox.2014.07.006